Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Patent suit against Apple will go forward

(5) Responding to Rumors

In principle, the Company does not comment when it receives inquiries about rumors. However, in cases where the Company believes it would be significantly affected by a rumor if that rumor were not addressed, the Company will quickly identify the source of the rumor and take appropriate actions as necessary.

(6) Quiet Period

To prevent leakage of financial information and ensure fair disclosure, the Company designates the three-week period ending the date of announcement of its financial results as the "quiet period." During this period, the Company will neither comment upon nor respond to queries concerning its financial results. If, however, the Company becomes aware of major discrepancy between its performance forecast and its actual financial results, it will publicly announce this discrepancy according to rules of timely disclosure. The Company will also respond to questions about previously disclosed information, even during the quiet period.

Six Months Ended Results Announcement
(reported on October 31, 2007)

Results for the Six Months Ended
September 30,2007

Fact Book (385KB)

copyright 2007 Mitsui Fudosan Co., Ltd. All Rights Reserved.
Share
New Message
Please login to post a reply